About F.A.Scheeren
My team is multidisciplinary and active in innate immune checkpoints, therapeutic antibodies and T-cell immunity in relation to cancer and infections. Using genetic engineering and biochemistry we create unique protein based tools and use these tools to answer clinically relevant biological questions.
Popular Content
Antibody conjugates are vital in research, diagnostics, and therapeutics. Creating homogenous multimeric products remains challenging. Our study introduces ubi-tagging, a modular protein engineering platform using ubiquitination for site-directed antibody conjugation, innovating the process.